Monitoring of adenovirus (ADV)-specific T cells in a boy with ADV pneumonia and disseminated disease after lung transplantation

Transplant Infectious Disease

Volumn 18, Issue 5, 2016, Pages 756-760

  Schultze Florey, R E ^a   Tischer, S ^a   Schwerk, N ^a   Heim, A ^a   Eiz Vesper, B ^a   Maecker Kolhoff, B ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

adenovirus; ADV; ADV specific T cells; lung transplantation; monitoring; pediatric

Indexed keywords

CIDOFOVIR; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; PREDNISOLONE; STEROID; TACROLIMUS; ANTIVIRUS AGENT; CYTOSINE; PHOSPHONIC ACID DERIVATIVE;

ACUTE GRAFT REJECTION; ANTIVIRAL THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BRONCHOALVEOLAR LAVAGE FLUID; CASE REPORT; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHILD; CONGENITAL DIAPHRAGM HERNIA; DISEASE SEVERITY; ENZYME LINKED IMMUNOSPOT ASSAY; FEVER; GRAFT RECIPIENT; HEART ATRIUM SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HUMAN ADENOVIRUS 2; HUMAN ADENOVIRUS C; HUMAN ADENOVIRUS INFECTION; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; LUNG GRAFT REJECTION; LUNG HYPOPLASIA; LUNG TRANSPLANTATION; MALE; MIXED INFECTION; PATIENT MONITORING; PNEUMONIA; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SEPSIS; T LYMPHOCYTE; TRICUSPID VALVE REPAIR; VIRUS DETECTION; VIRUS LOAD; VIRUS PNEUMONIA; ADENOVIRIDAE; ADENOVIRUS INFECTIONS, HUMAN; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; FEASIBILITY STUDY; FLOW CYTOMETRY; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; ISOLATION AND PURIFICATION; PHYSIOLOGIC MONITORING; PNEUMONIA, VIRAL; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; VIROLOGY;

ADENOVIRIDAE; ADENOVIRUS INFECTIONS, HUMAN; ANTIVIRAL AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; CHILD, PRESCHOOL; CYTOSINE; ENZYME-LINKED IMMUNOSPOT ASSAY; FEASIBILITY STUDIES; FLOW CYTOMETRY; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSION; LUNG TRANSPLANTATION; MALE; MONITORING, PHYSIOLOGIC; ORGANOPHOSPHONATES; PNEUMONIA, VIRAL; REAL-TIME POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; VIRAL LOAD;

EID: 84989332687     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/tid.12569     Document Type: Article

References (15)

1. Humar A, Doucette K, Kumar D, et al. Assessment of adenovirus infection in adult lung transplant recipients using molecular surveillance. J Heart Lung Transplant 2006; 25 (12): 1441–1446.
2. Doan ML, Mallory GB, Kaplan SL, et al. Treatment of adenovirus pneumonia with cidofovir in pediatric lung transplant recipients. J Heart Lung Transplant 2007; 26 (9): 883–889.
3. Matthes-Martin S, Feuchtinger T, Shaw PJ, et al. European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation:summary of ECIL-4 (2011). Transpl Infect Dis 2012; 14 (6): 555–563.
4. Farace O, Godfrin D, Gaston J, Lengagne RE, Tursz T, Boulanger P. Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity. J Virol 1998; 72 (3): 2388–2397.
5. + cytotoxic T cell responses to adenovirus capsid proteins. Virology 2006; 350 (2): 312–322.
6. Feuchtinger T, Lücke J, Hamprecht K, et al. Detection of adenovirus-specific T cells in children with adenovirus infection after allogeneic stem cell transplantation. Br J Haematol 2005; 128 (4): 503–509.
7. Geyeregger R, Freimüller C, Stevanovic S, et al. Short-term in-vitro expansion improves monitoring and allows affordable generation of virus-specific T-cells against several viruses for a broad clinical application. PLoS One 2013; 8 (4): e59592.
8. Günther PS, Peper JK, Faist B, et al. Identification of a novel immunodominant HLA-B*07. J Immunother 2015; 38 (7): 267–275.
9. + T cells. Blood 2004; 104 (8): 2432–2440.
10. Leen AM, Christin A, Khalil M, et al. Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy. J Virol 2008; 82 (1): 546–554.
11. Ganzenmueller T, Heim A. Adenoviral load diagnostics by quantitative polymerase chain reaction: techniques and application. Rev Med Virol 2012; 22 (3): 194–208.
12. Mynarek M, Ganzenmueller T, Mueller-Heine A, et al. Patient, virus, and treatment-related risk factors in pediatric adenovirus infection after stem cell transplantation: results of a routine monitoring program. Biol Blood Marrow Transplant 2014; 20 (2): 250–256.
13. Tischer S, Dieks D, Sukdolak C, et al. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches. J Immunol Methods 2014; 408: 101–113.
14. Benden C, Goldfarb SB, Edwards LB, et al. The registry of the International Society for Heart and Lung Transplantation: seventeenth official pediatric lung and heart-lung transplantation report–2014; focus theme: retransplantation. J Heart Lung Transplant 2014; 33 (10): 1025–1033.
15. Feuchtinger T, Matthes-Martin S, Richard C, et al. Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. Br J Haematol 2006; 134 (1): 64–76.